Ru 486 Misconceptions Myths and Morals - ressourcesfeministes

RU 486(Mifepristone), a new antiprogestagen with potential therapeuticuse in human fertility control. Drugs 35:187–191.Couzinet, Beatrice, Le Strat, Nelly, Silvestre, Louise and Schaison,Gilbert. (1990). Late luteal administration of the antiprogesteroneRU 486* in normal women: effects on the menstrual cycle eventsand fertility control in a long-term study. Fertility and Sterility 54(6): 1039–1044.Crooij, Marinus J., de Nooyer, Coenraad C.A., Rao, Ramanath,Berends, Gerrit T., Gooren, Louis J.G. and Janssens, Jannes.(1988). Termination of early pregnancy by the 3ß-hydroxysteroiddehydrogenase inhibitor epostane. The New England Journal ofMedicine 319:813–817.Crowley, William. (1986). Progesterone antagonism. The New EnglandJournal of Medicine 315 (25): 1607–1608.Csapo, Arpad I., Pulkkinen, Martti O. and Weist, W.G. (1973). Effectsof lutectomy and progesterone replacement therapy in earlypregnant patients. American Journal of Obstetrics and Gynecology115:759–765.Csapo, Arpad I., Pulkkinen, Martti O., Ruttner, B., Sauvage, J.P. andWeist, W.G. (1972). The significance of the human corpus luteumin pregnancy maintenance. American Journal of Obstetrics andGynecology 112:1061–1067.Csapo. Arpad I., Sauvage, J.P. and Weist, W.G. (1971). The efficacyand acceptability of intravenously administered prostaglandinF 2•as an abortifacient. American Journal of Obstetrics and Gynecology111:1059–1063.Das, Chandra and Catt, Kevin J. (1987). Antifertility actions of theprogesterone antagonist RU 486 include direct inhibition of placentalhormone secretion. The Lancet ii (12 September): 599–661.de la Fuente, Martha. (1989). Letter to the Editor. Women’s GlobalNetwork for Reproductive Rights, Newsletter (Oct/Dec) 31:3–4.Delaney, Anne. (1990,19 November). The Health Report RadioNational, Australia.136